[JAMA] Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma

tarekcnn Post time Yesterday 22:25 | Show all posts |Read mode
This post will be closed automatically in 2026-07-28 22:25
Reward10points

journalㄩJAMA Oncology

AuthorsㄩAlexander N. Shoushtari; Claire F. Friedman; Pedram Navid-Azarbaijani; Michael A. Postow; Margaret K. Callahan; Parisa Momtaz; Katherine S. Panageas; Jedd D. Wolchok; Paul B. Chapman

Published dateㄩ2018-1-1

DOIㄩ10.1001/jamaoncol.2017.2391

PDF linkㄩhttp://oncology.jamanetwork.com/ ... jamaoncol.2017.2391

Article linkㄩhttps://doi.org/10.1001/jamaoncol.2017.2391

Article SourceㄩAmerican Medical Association (AMA)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list